Latest News and Press Releases
Want to stay updated on the latest news?
-
YONKERS, NY--(Marketwired - Sep 30, 2014) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein...
-
YONKERS, NY--(Marketwired - Sep 24, 2014) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein...
-
YONKERS, NEW YORK--(Marketwired - Sep 19, 2014) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on protein and antibody therapeutic products...
-
YONKERS, NY--(Marketwired - Sep 16, 2014) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein...
-
YONKERS, NY--(Marketwired - Sep 9, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
-
YONKERS, NY--(Marketwired - Sep 3, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
-
YONKERS, NY--(Marketwired - Sep 2, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
-
YONKERS, NY--(Marketwired - Aug 27, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
-
YONKERS, NY--(Marketwired - Aug 4, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
-
YONKERS, NY--(Marketwired - Jul 29, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...